Epigenetic changes, including CpG island hypermethylation, occur frequently in bladder cancer (BC) and may be exploited for BC detection and distinction between high-grade (HG) and low-grade (LG) disease. Genome-wide methylation analysis was performed using Agilent Human CpG Island Microarrays to de...
To predict survival outcomes for individual patients with clinical T1 high-grade (T1HG) bladder cancer (BC), data from the Surveillance Epidemiology and End Results (SEER) database were analyzed in the present study. The data of 6,980 cases of T1HG BC between 2004 and 2014 were obtained ...
In this study, we characterized the metabolic profiles of one-hundred patients suffering from bladder cancer, in an effort to develop serum-specific metabolic signatures for early and specific detection of bladder cancer. For this purpose, we recorded ultra-high-resolution LC–MS spectra of 200 tot...
This cohort study examines the overall survival in men with very high-risk prostate cancer who are treated with radiotherapy and hormone therapy at
Patients with high grade Ta tumors have a lifelong risk of disease stage progression and death from bladder cancer similar to those with T1 tumors. 展开 关键词: bladder neoplasms carcinoma, papillary DOI: 10.1016/S0022-5347(05)67972-4
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both pr... We confirmed a high rate of clinical understaging in this cohort, especially among patients showing lymphovascular invasion on biopsy. ...
in which patients with high-grade T1 (HGT1) bladder cancer were treated by transurethral resection with either white-light cystoscopy or fluorescence cystoscopy. Over a median follow-up duration >7 years, the recurrence-free survival was significantly improved in the fluorescence cystoscopy group. No...
High-risk breast cancer is defined in this volume as a disease with a high probability of dissemination, implying aggressive behavior, presence of micrometastases at diagnosis, resistance to therapy and ultimate recurrence with poor overall survival. Thi
CIP2A protein expression in high-grade, high-stage bladder cancer. Cancer Med 2012; 1: 76–81. 43 Teng H-W, Yang S-H, Lin J-K, Chen W-S, Lin T-C, Jiang J-K et al. CIP2A is a predictor of poor prognosis in colon cancer. J Gastrointest Surg 2012; 16: 1037–1047. 44 He...
The actuarial 3.5-year bC rate was 87.6%. PSA bouncing occurred in 4 47 Int J Clin Exp Med 2011;4(1):43-52 hEBRT and hEBRT for prostate cancer Figure 1. Hazard function for late GU-toxicity > grade 2 and urethral dose. (10.2%) patients in a median time of 15 months (range, ...